dbDNA vector gene therapy expressing FIX (Touchlight Genetics/Seattle Children's Research Institute/University of Washington)

N/A

Report date: 2025/01/26 18:40:40

Base Information

Drug NamedbDNA vector gene therapy expressing FIX (Touchlight Genetics/Seattle Children's Research Institute/University of Washington)
Drug Alias Namenon-viral vector gene therapy expressing FIX (Touchlight Genetics/Seattle Children's Research Institute/University of Washington)FIX gene therapy (Touchlight Genetics/Seattle Children's Research Institute/University of Washington)FIX gene therapy (Touchlight Genetics/Seattle Children's Research Institute/University of Washington)
ClassificationBiologics
Mechanisms of ActionCoagulation factor IX modulators
TargetsCoagulation factor IX
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Washington
China Registration ClassN/A

Develop Information

Active CompaniesSeattle Children'S Research InstituteUniversity Of WashingtonTouchlight Genetics Ltd
Inactive CompaniesN/A
Active IndicationsHemophilia B
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A